Association between antidepressants use during pregnancy and autistic spectrum disorders: A meta-analysis

Innovations in Clinical Neuroscience

Volumn 11, Issue 5-6, 2014, Pages 18-22

  Rais, Theodor B ^a   Rais, Alexandra ^b  

^a UNIVERSITY OF TOLEDO MEDICAL CENTER   (United States)

^b UNIVERSITY OF TOLEDO   (United States)

Author keywords

Antidepressants; Autistic spectrum disorders; Meta analysis; Neurodevelopmental delays; Pregnancy; R stats software

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; AUTISM; CASE CONTROL STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG EXPOSURE; HUMAN; META ANALYSIS; NERVE CELL DIFFERENTIATION; PREGNANCY; RISK FACTOR;

EID: 84938060127     PISSN: 21588333     EISSN: 21588341     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Evans J, Heron J, Francomb H, et al. Cohort study of depressed mood during pregnancy and after childbirth.” BMJ. 2001;323(7307):257–260.
2. Bennett HA, Einarson A, Taddio A, et al. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol. 2004;103(4):698–709.
3. Casper RC, Fleisher BE, Lee- Ancajas JC. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr. 2003;142(4):402–408.
4. Mortensen JT, Olsen J, Larsen H, et al. Psychomotor development in children exposed in utero to benzodiazepines, antidepressants, neuroleptics, and anti-epileptics. Eur J Epidemiol. 2003;18(8):769–771.
5. Kanner L. Autistic disturbances of affective contact. Nervous Child. 1943;2:217–50.
6. Muhle R, Trentacoste SV, Rapin I. The genetics of autism. Pediatrics. 2004;113(5):e472–486.
7. De las Cuevas C, Sanz EJ. Safety of selective serotonin reuptake inhibitors in pregnancy. Curr Drug Saf. 2006;1(1):17–24.
8. Rai D, Lee BK, Dalman C, et al. Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ. 2013 Apr 19;346:f2059. doi: 10.1136/bmj.f2059.
9. Croen LA, Grether JK, Yoshida CK, et al. Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry. 2011 Nov;68(11): 1104-12. doi: 10.1001/archgenpsychiatry.2011.73. Epub 2011 Jul 4.
10. Pedersen LH. Fetal exposure to antidepressants and normal milestone development at 6 and 19 months of age. Pediatrics. 2010;125;e600.
11. Nulman I, Rovet J, Stewart DE, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med. 1997;336(4):258–262.
12. Nulman I, Rovet J, Stewart DE, et al. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry. 2002;159(11):1889–1895.
13. Nulman I, Koren G, Rovet J, et al. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am J Psychiatry. 2012;169(11): 1165–1174.
14. Casper RC, Fleisher BE, Lee-Ancajas JC, et al. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr. 2003;142(4):402–408.
15. Laugesen K, Olsen MS, Telén Andersen AB, et al. In utero exposure to antidepressant drugs and risk of attention deficit hyperactivity disorder: a nationwide Danish cohort study. BMJ. 2013 Sep 20;3(9):e003507. doi: 10.1136/bmjopen-2013-003507.
16. Sorensen MJ, Gronborg TK et al, Antidepressant exposure in pregnancy and risk of autism spectrum disorders. Clin Epidemiol. 2013;5:449–459
17. Oberlander TF, Papsdorf M, Brain UM, et al. Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age. Arch Pediatr Adolesc Med. 2010;164(5):444–451.
18. Chen DG, Peace KE. Applied metaanalysis with R. Boca Raton, FL: CRC Press; 2013.